NCT00070083 2009-04-07Oblimersen, Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell LymphomaNational Cancer Institute (NCI)Phase 1 Completed